Principal Financial Group
NKTR icon

Principal Financial Group’s Nektar Therapeutics NKTR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,454
Closed -$7.79K 2290
2025
Q1
$7.79K Buy
11,454
+687
+6% +$467 ﹤0.01% 2165
2024
Q4
$10K Sell
10,767
-1,688
-14% -$1.57K ﹤0.01% 2204
2024
Q3
$16.2K Sell
12,455
-5,050
-29% -$6.57K ﹤0.01% 2212
2024
Q2
$21.7K Sell
17,505
-32,951
-65% -$40.9K ﹤0.01% 2335
2024
Q1
$47.1K Sell
50,456
-1,556
-3% -$1.45K ﹤0.01% 2351
2023
Q4
$29.4K Sell
52,012
-5,781
-10% -$3.27K ﹤0.01% 2366
2023
Q3
$34.4K Buy
57,793
+4,759
+9% +$2.83K ﹤0.01% 2375
2023
Q2
$30.5K Sell
53,034
-1,107,896
-95% -$637K ﹤0.01% 2391
2023
Q1
$816K Sell
1,160,930
-16,867
-1% -$11.9K ﹤0.01% 1880
2022
Q4
$2.66M Buy
1,177,797
+3,212
+0.3% +$7.26K ﹤0.01% 1709
2022
Q3
$3.76M Buy
1,174,585
+5,340
+0.5% +$17.1K ﹤0.01% 1586
2022
Q2
$4.44M Sell
1,169,245
-86,356
-7% -$328K ﹤0.01% 1593
2022
Q1
$6.77M Sell
1,255,601
-6,198
-0.5% -$33.4K ﹤0.01% 1544
2021
Q4
$17M Buy
1,261,799
+589,861
+88% +$7.97M 0.01% 1061
2021
Q3
$12.1M Sell
671,938
-3,720
-0.6% -$66.8K 0.01% 1302
2021
Q2
$11.6M Buy
675,658
+9,902
+1% +$170K 0.01% 1352
2021
Q1
$13.3M Buy
665,756
+97,703
+17% +$1.95M 0.01% 1228
2020
Q4
$9.66M Buy
568,053
+570
+0.1% +$9.69K 0.01% 1251
2020
Q3
$9.41M Sell
567,483
-16,819
-3% -$279K 0.01% 1117
2020
Q2
$13.5M Buy
584,302
+27,396
+5% +$634K 0.01% 870
2020
Q1
$9.94M Sell
556,906
-215,824
-28% -$3.85M 0.01% 909
2019
Q4
$16.7M Buy
772,730
+500,466
+184% +$10.8M 0.01% 941
2019
Q3
$4.96M Sell
272,264
-7,018
-3% -$128K ﹤0.01% 1521
2019
Q2
$9.94M Sell
279,282
-10,630
-4% -$378K 0.01% 1222
2019
Q1
$9.74M Buy
289,912
+1,685
+0.6% +$56.6K 0.01% 1243
2018
Q4
$9.47M Buy
288,227
+2,637
+0.9% +$86.7K 0.01% 1211
2018
Q3
$17.4M Buy
285,590
+39,389
+16% +$2.4M 0.02% 956
2018
Q2
$12M Sell
246,201
-120,363
-33% -$5.88M 0.01% 1192
2018
Q1
$39M Sell
366,564
-1,039,693
-74% -$110M 0.04% 474
2017
Q4
$84M Sell
1,406,257
-51,750
-4% -$3.09M 0.08% 297
2017
Q3
$35M Sell
1,458,007
-71,943
-5% -$1.73M 0.03% 504
2017
Q2
$29.9M Buy
1,529,950
+58
+0% +$1.13K 0.03% 568
2017
Q1
$35.9M Buy
1,529,892
+40,847
+3% +$959K 0.04% 444
2016
Q4
$18.3M Buy
1,489,045
+160,962
+12% +$1.98M 0.02% 753
2016
Q3
$22.8M Buy
1,328,083
+51,490
+4% +$885K 0.03% 583
2016
Q2
$18.2M Buy
1,276,593
+22,227
+2% +$316K 0.03% 671
2016
Q1
$17.2M Buy
1,254,366
+46,162
+4% +$635K 0.03% 657
2015
Q4
$20.4M Buy
1,208,204
+56,510
+5% +$952K 0.03% 559
2015
Q3
$12.6M Buy
1,151,694
+35,564
+3% +$390K 0.02% 780
2015
Q2
$14M Buy
1,116,130
+825,181
+284% +$10.3M 0.02% 766
2015
Q1
$3.2M Buy
290,949
+3,907
+1% +$43K ﹤0.01% 1544
2014
Q4
$4.45M Sell
287,042
-19,488
-6% -$302K 0.01% 1435
2014
Q3
$3.7M Buy
306,530
+5,049
+2% +$60.9K 0.01% 1485
2014
Q2
$3.87M Sell
301,481
-9,062
-3% -$116K 0.01% 1508
2014
Q1
$3.76M Buy
310,543
+285,103
+1,121% +$3.46M 0.01% 1491
2013
Q4
$289K Sell
25,440
-5,490
-18% -$62.4K ﹤0.01% 2015
2013
Q3
$323K Sell
30,930
-4,972
-14% -$51.9K ﹤0.01% 1938
2013
Q2
$415K Buy
+35,902
New +$415K ﹤0.01% 1860